Literature DB >> 19794094

HAMP promoter mutation nc.-153C>T in 785 HEIRS study participants.

James C Barton, Catherine Leiendecker-Foster, Honggui Li, Susie DelRio-LaFreniere, Ronald T Acton, John H Eckfeldt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19794094      PMCID: PMC2754967          DOI: 10.3324/haematol.2009.011486

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.

Authors:  P L Lee; T Gelbart; C West; C Halloran; V Felitti; E Beutler
Journal:  Blood Cells Mol Dis       Date:  2001 Sep-Oct       Impact factor: 3.039

2.  Hemochromatosis and iron-overload screening in a racially diverse population.

Authors:  Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

3.  Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants.

Authors:  XinJing Wang; Catherine Leiendecker-Foster; Ronald T Acton; James C Barton; Christine E McLaren; Gordon D McLaren; Victor R Gordeuk; John H Eckfeldt
Journal:  Blood Cells Mol Dis       Date:  2009-01-26       Impact factor: 3.039

4.  A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis.

Authors:  Marie-Laure Island; Anne-Marie Jouanolle; Annick Mosser; Yves Deugnier; Véronique David; Pierre Brissot; Olivier Loréal
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

5.  Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD.

Authors:  Guillem Casanovas; Katarzyna Mleczko-Sanecka; Sandro Altamura; Matthias W Hentze; Martina U Muckenthaler
Journal:  J Mol Med (Berl)       Date:  2009-02-20       Impact factor: 4.599

6.  Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.

Authors:  Luca Valenti; Edoardo A Pulixi; Paolo Arosio; Laura Cremonesi; Giorgio Biasiotto; Paola Dongiovanni; Marco Maggioni; Silvia Fargion; Anna Ludovica Fracanzani
Journal:  Haematologica       Date:  2007-07-20       Impact factor: 9.941

  6 in total
  4 in total

1.  Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.

Authors:  Ronald T Acton; James C Barton; Catherine Leiendecker-Foster; Christopher Zaun; Christine E McLaren; John H Eckfeldt
Journal:  Blood Cells Mol Dis       Date:  2010-02-23       Impact factor: 3.039

2.  HAMP promoter mutation nc.-153C>T in non p.C282Y homozygous patients with iron overload.

Authors:  Patricia Aguilar-Martinez; Muriel Giansily-Blaizot; Michael Bismuth; Séverine Cunat; Hélène Igual; Jean François Schved
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

3.  Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Gordon D McLaren; Victor R Gordeuk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

4.  Genetic study of the hepcidin gene (HAMP) promoter and functional analysis of the c.-582A > G variant.

Authors:  Silvia Parajes; Arturo González-Quintela; Joaquín Campos; Celsa Quinteiro; Fernando Domínguez; Lourdes Loidi
Journal:  BMC Genet       Date:  2010-12-10       Impact factor: 2.797

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.